Introduction {#S0001}
============

Gestational diabetes mellitus (GDM) is currently the most common medical complication of pregnancy. The documented prevalence of GDM varies substantially worldwide, ranging from 1% to 30%.[@CIT0001] Due to a lack of consensus and consistency in the screening and diagnostic criteria for GDM, it is challenging to compare the prevalence across countries and regions.[@CIT0001] According to one most recent systematic review and meta-analysis, in which the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria was used as the diagnostic criteria of GDM, the total incidence of GDM in mainland China can reach approximately 15%.[@CIT0002] GDM is defined as any degree of glucose intolerance that was first recognized during pregnancy.[@CIT0003],[@CIT0004] Many factors are considered to be risk factors for GDM, including mother's ethnicity, body composition, family history of diabetes, obesity, and polycystic ovary syndrome (PCOS).[@CIT0005],[@CIT0006] GDM has a variety of negative implications for mothers and their offspring. For mothers, GDM is associated with higher rates of preeclampsia, cesarean deliveries, shoulder dystocia, and type 2 diabetes mellitus in the postpartum period.[@CIT0005],[@CIT0007] On the other side, it is evident that the women with GDM are more likely to deliver large for gestational age (LGA) infant than nondiabetic mothers, which is an important determinant factor in perinatal morbidity and mortality.[@CIT0008] Furthermore, offspring born to mothers with GDM have a higher likelihood of developing obesity and of having impaired glucose tolerance (IGT) as well as type 2 diabetes in childhood or in early adulthood.[@CIT0005],[@CIT0009],[@CIT0010] Being overweight or obese or having IGT is one of significant risk factors for GDM, and this gives rise to a vicious intergenerational cycle of obesity and diabetes. Therefore, early prediction GDM may help in improved clinical management of pregnancy.

Pregnancy is a state of multiple and critical changes in the morphology and physiology of women, which play a fundamental role in meeting the mother's basal needs and the requirements of the developing fetus.[@CIT0011] Among the maternal physiological adaptations, alterations in lipid metabolism are more characteristic.[@CIT0012],[@CIT0013] The first 2 trimesters of pregnancy are an anabolic phase, which is attributed to several factors that cooperatively increase the deposition of fat in maternal tissues,[@CIT0012],[@CIT0014] including maternal hyperphagia, enhanced lipogenesis, and decreased adipose tissue lipolytic activity. As a result, those maternal factors result in net triglyceride accumulation.[@CIT0012] Along with the changes of adipose tissue during pregnancy, serum triglycerides (TG), lipoproteins and cholesterol alter as well. In a large cross-sectional study, TG, total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-c) levels decreased between the time of conception and 8 weeks of gestation and then gradually increased and peaked just before delivery.[@CIT0015] In a prospective cohort study, the mean serum concentrations of those lipids including TG, TC, and LDL increased from the first trimester to the third trimester.[@CIT0016] Increasing evidence has suggested that hypertriglyceridemia, even in early pregnancy,[@CIT0017] is likely to be associated with insulin resistance,[@CIT0018],[@CIT0019] as well as GDM.[@CIT0020],[@CIT0021] In addition, fasting plasma glucose (FPG) at the first prenatal visit is related to glycemic metabolism in the mid-gestational period, as suggested in a previous study.[@CIT0022] Moreover, a recent study has reported that high FPG or BMI in the first trimester of pregnancy is independently associated with later development of GDM.[@CIT0023] Therefore, it is suggested that the evaluation of maternal first-trimester serum concentrations of TG, lipoproteins, cholesterol and FPG may be of great significance for the prediction of complications in later pregnancy.

Recently, two triglyceride-associated markers, ratio of TG to high-density lipoprotein cholesterol (TG/HDL-c) and triglyceride glucose index (TyG), have been proposed as indicators of insulin resistance,[@CIT0024]--[@CIT0027] which is the principal pathophysiology of GDM.[@CIT0006] Not only in the general population, but also in pregnant women, these two indices have been reported to be useful in monitoring insulin resistance during pregnancy,[@CIT0028] as well as in predicting the risk of GDM and LGA newborn.[@CIT0029],[@CIT0030] However, it is still unclear whether these indices have the same or different potential in predicting GDM or LGA infant delivery.

The aim of this study was to evaluate the associations of these two TG-associated indices as well as TC/HDL-c of early pregnancy with the risk of developing GDM and delivering LGA newborn, using data from a mother-offspring cohort study where the correlation between the single nucleotide polymorphism (SNP) of the nutrient-associated genes and the maternal nutrient status were investigated.

Materials and Methods {#S0002}
=====================

Ethical Statement {#S0002-S2001}
-----------------

The study protocol was approved by the Ethics Committee of Peking Union Medical College Hospital of the Chinese Academy of Medical Science (Date of approval: 24-July-2018; ref. no., hs-1646). This study was conducted in accordance with both the Declaration of Helsinki of 1975, as revised in 1983, and guidelines of the centre's institutional review board. All the participants were informed of the details of the study, and each participant provided written informed consent.

Participants {#S0002-S2002}
------------

The recruitment of participants in this cohort took place during October and December 2018 at the Shunyi District Maternal and Child Health Hospital (Beijing, PR China), where women in early pregnancy were approached to participate. All the women are local residents in Shunyi District of Beijing, and they had established prenatal records before recruitment. At first, a total of 432 pregnant women agreed to participate in this cohort. A standard questionnaire was used by trained researchers to collect information, including age, ethnicity (self-report), smoking status, drinking status, education (senior middle school or lower/college degree or higher), physical activity (0--150mins or ≥ 150mins moderate exercise time per week), parity (primiparous or multiparous), medical history, family history of diabetes (yes/no). Women were excluded if they had any of the following criteria: (1) not a singleton pregnancy; (2) those who are not the Han ethnicity (to avoid possible confounding by ethnicity); (3) those who lab-testing fasting glucose ≥ 6.1 mmol/L and/or HbA1c \> 6.5% or diagnosed as diabetes before pregnancy; (4) those who with a history of autoimmune disease (such as systemic lupus erythematosus, etc) or currently use corticosteroids; (5) those who with define hyperthyroidism or hypothyroidism; (6) those who miscarried or induced labor before the 75-g oral glucose tolerance test (OGTT) at 24--28 weeks' gestation; (7) those who with a history of liver or renal insufficiency or with presumed acute inflammation (CRP \> 10 mg/L); (8) those who with a suspected familial hypertriglyceridemia (serum TG ≥ 5.1 mmol/L); (9) those who without complete records of lipid profiles and/or FPG concentration.

Height was measured to nearest 0.1 cm with a portable stadiometer. Weight was measured in an upright position to the nearest 0.1 kg with a calibrated scale. Body mass index (BMI) was calculated as weight (kg)/height (m).[@CIT0002] During the whole course of pregnancy, the routine prenatal examination for each participant was performed in the same hospital. At 24--28 weeks' gestation, a 75-g OGTT was conducted in all participants. The diagnosis of GDM was using IADPSG/WHO criteria where one or more glucose values from a 75-g OGTT equaled or exceeded the following thresholds: FPG 5.1 mmol/L, 1-h plasma glucose (PG) 10.0 mmol/L, and 2-h PG 8.5 mmol/L.[@CIT0031] After delivery, all the related data were sourced from medical records. LGA was defined as birthweight \> 90th percentile for gestational age and sex.[@CIT0032] Finally, a total of 352 women with completed data were eligible for this study. The participant flowchart was presented in [Figure 1](#F0001){ref-type="fig"}.Figure 1Participant flowchart.

Measurements {#S0002-S2003}
------------

Blood samples were collected from the peripheral vein of participants during the first visit before 12 weeks' gestation, after an overnight (at least 8 hours) fast. Maternal FPG, TC, TG, HDL-c, LDL-c, and CRP concentrations during the first trimester of pregnancy were measured by an automatic analyser (Beckman 5800; Beckman Coulter Inc., Brea, CA, USA) and retrieved from medical records. Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated as follows:

HOMA-IR= (fasting plasma glucose \[mmol/L\] × fasting serum insulin \[μIU/L\])/22.5

TyG was calculated as: TyG = Ln \[TG (mg/dl) FPG (mg/dl)/2\][@CIT0033]

Statistical Analysis {#S0002-S2004}
--------------------

Statistical analyses were performed using the Statistical Software Package for Social Science (SPSS version 16.0, Chicago, IL, USA). Normally distributed variables were presented as mean (standard deviation), while skewed variables were presented as median (interquartile range, 25--75%). Categorical variables were described as frequency or percentage and examined by the Chi square test. The independent-sample *t*-test or the Mann--Whitney *U*-test, when appropriate, was used to compare variables with normal or skewed distribution between the GDM group and the non-GDM group. Spearman correlations were applied to assess the correlations between the indices and variables including age, BMI, HOMA-IR, and CRP. TG/HDL-c (T1, \< 0.49; T2, 0.49--0.74; T3, ≥ 0.75), TyG (T1, \< 7.9; T2, 7.9--8.3; T3, ≥ 8.3), and TC/HDL-c (T1, \< 2.5; T2, 2.5--2.9; T3, ≥ 2.9) were divided into tertiles according to their respective cut-off points of entire distribution for this study population. Binary logistic regression analyses were performed to determine the odds ratio (ORs) and 95% confidence intervals (CIs) of GDM and LGA according to respective tertiles of the three indices with adjusting for potential covariates. Receiving-operating characteristic (ROC) curves and areas under the curve (AUC) were employed to evaluate the ability of the indices to detect GDM and LGA newborn. A comparison of the diagnostic abilities between the indices was performed using the AUC, and the significance of differences between their AUC values was also assessed using the method described by DeLong.[@CIT0034]

Results {#S0003}
=======

Maternal and Infant Characteristics {#S0003-S2001}
-----------------------------------

In our study, none of the women smoke or drink for at least three months before enrolment, thus we did not show the data on smoking and drinking status. The prevalence of GDM was 18.8% (n=66) in this study. Compared with women without GDM, women with GDM had significantly higher age, BMI (at enrolment), TG, LDL-c, FPG, HOMA-IR, CRP, TG/HDL-c, TyG, TC/HDL-c, and percentage of family history of diabetes, but a less (*P* = 0.017) exercise time per week, a lower trend in HDL-c (*P* = 0.058) and a higher trend in the incidence of cesarean section (*P* = 0.068). No significant differences in parity, education, weight gain and percentage of history of PCOS were found between women with and without GDM ([Table 1](#T0001){ref-type="table"}).Table 1Maternal and Infant CharacteristicsVariablesAll (n=352)GDM (n=66)Non-GDM (n=286)*P***Maternal characteristics**Age (years)29.2 (3.6)30.4 (4.0)29.0 (3.5)0.007Body mass index (kg/m^2^)22.8 (3.7)24.3 (3.6)22.4 (3.6)\<0.001Weight gain (kg)^a^9.3 (4.6)9.4 (4.4)9.0 (5.5)0.078Weight gain (kg)^b^15.1 (5.8)14.1 (6.7)15.3 (5.5)0.224Total cholesterol (mmol/L)4.20 (0.69)4.29 (0.71)4.17 (0.68)0.194Triglyceride (mmol/L)0.93 (0.72--1.21)1.10 (0.87--1.46)0.90 (0.71--1.15)\<0.001HDL-c (mmol/L)1.54 (0.28)1.49 (0.26)1.56 (0.28)0.058LDL-c (mmol/L)2.0 (0.54)2.15 (0.58)1.96 (0.53)0.013TG/HDL-c ratio0.60 (0.46--0.85)0.73 (0.55--1.05)0.58 (0.44--0.80)\<0.001TC/HDL-c ratio2.71 (2.42--3.09)2.88 (2.55--3.27)2.65 (2.37--3.02)0.002Fasting plasma glucose (mmol/L)4.5 (4.2--4.7)4.7 (4.4--5.0)4.4 (4.1--4.7)\<0.001Triglyceride glucose index8.1 (0.5)8.3 (0.4)8.0 (0.4)\<0.001HOMA-IR1.52 (1.05--2.29)2.11 (1.40--3.07)1.40 (1.00--2.08)\<0.001C-reactive protein (mg/L)2.1 (0.9--4.0)3.3 (1.5--5.9)1.9 (0.8--3.5)\<0.001Family history of DM31 (8.8)11 (16.7)20 (7.0)0.012Parity Primiparous209 (59.4)37 (56.1)172 (60.1)0.543 Multiparous143 (40.6)29 (43.9)114 (39.9)History of PCOS6 (1.7)2 (3.0)4 (1.4)0.356Education Senior middle school or lower73 (20.7)12 (18.2)61 (21.3)0.570 College degree or higher279 (79.3)54 (81.8)225 (78.7)Physical activity 0--150mins per week188 (53.4)44 (66.7)144 (50.3)0.017 ≥150mins per week164 (46.6)22 (33.3)142 (49.7)Cesarean section106 (30.1)26 (39.4)80 (28.0)0.068**Infant characteristics**Gestational age39 (38--40)39 (38--40)39 (38--40)0.114Sex (male)191 (54.3)38 (57.6)153 (53.5)0.549Birth weight (g)3369 (476)3412 (595)3359 (447)0.512LGA31 (8.8)13 (19.7)18 (6.3)0.001[^1][^2]

On the neonate side, the overall prevalence of LGA was 8.8% (n=31), and there was a significant difference in the prevalence of LGA in women with and without GDM (*P* = 0.001), and there were no significant differences between groups in gestational age, birth weight and infant sex ([Table 1](#T0001){ref-type="table"}).

Correlations Between the Triglyceride-Associated Indices and Markers of Inflammation and Insulin Resistance {#S0003-S2002}
-----------------------------------------------------------------------------------------------------------

Spearman correlation analysis showed that all the indices were significantly correlated with maternal age, BMI (at enrolment), HOMA-IR, and CRP (all *P* \< 0.01, [Table 2](#T0002){ref-type="table"}). In addition, there was a high correlation among the three indices (*P* \< 0.001).Table 2Spearman Correlation Between the Indices and Age, BMI and Markers of Inflammation and Insulin ResistanceVariablesTG/HDL-cTyGTC/HDL-cCoefficient*P*Coefficient*P*Coefficient*P*Age (years)0.17\<0.010.21\<0.010.14\<0.01BMI (kg/m^2^)0.40\<0.010.39\<0.010.43\<0.01HOMA-IR0.39\<0.010.43\<0.010.37\<0.01CRP (mg/L)0.46\<0.010.53\<0.010.28\<0.01[^3]

Associations Between the Tertiles of the Two Indices and the Risk of Developing GDM and Delivering LGA Infant {#S0003-S2003}
-------------------------------------------------------------------------------------------------------------

Values of TG/HDL-c, TyG index, and TC/HDL-c were divided into tertiles and their lowest tertiles were used as reference, respectively. Then, binary logistic regression analyses were used to explore the associations between the quartiles of the two indices and GDM risk, respectively ([Table 3](#T0003){ref-type="table"}). Women in the upper two tertiles of TC/HDL-c values did not have a significantly higher risk of GDM or LGA delivery than those in the lowest tertile after adjustment for covariates (all *p* \> 0.05).Table 3Associations Between Tertiles of the Indices and the Risk of GDM and LGA InfantsTertiles of IndicesLGA (n)Adjusted Odds Ratio (95% Confidence Interval)GDM (n)GDM^†^LGA Infant‡TG/HDL-cTertile 1114ReferenceReferenceTertile 222101.862 (0.804--4.313)2.475 (0.722--8.482)Tertile 333172.388 (1.026--5.467)\*3.742 (1.114--12.569)\*TyG indexTertile 1106ReferenceReferenceTertile 21972.273 (0.959--5.387)1.057 (0.325--3.431)Tertile 337183.535 (1.483--8.426)\*\*3.011 (1.012--8.962)\*TC/HDL-cTertile 1146ReferenceReferenceTertile 22171.261 (0.578--2.750)1.085 (0.342--3.442)Tertile 331181.683 (0.772--3.666)2.584 (0.893--7.362)[^4]

For TG/HDL-c, compared to women in the lowest tertile, women in the highest tertile had a higher risk of developing GDM \[adjusted OR=2.388, 95% CI (1.026--5.467), *P* \< 0.05\] after adjusting for covariates, including maternal age, BMI at enrolment, weight gain (from enrolment to the 75-g OGTT), education, physical activity, parity, family history of diabetes, history of PCOS, and CRP, and they also had a significantly higher risk of delivering LGA infants \[adjusted OR=3.742, 95% CI (1.114--12.569), *P* \< 0.05\] after labor method, fetal sex, gestation age, and weight gain (from enrolment to before childbirth) were further adjusted following above maternal covariates.

As for TyG, compared with women in the reference tertile, women in the highest tertile also had a significantly higher risk of developing GDM \[adjusted OR=3.535, 95% CI (1.483--8.426), *P* \< 0.01\] and delivering LGA infants \[adjusted OR=3.011, 95% CI (1.012--8.962), *P* \< 0.05\] after adjusting for the same covariates as above, respectively.

However, the associations between the two indices and the risk of LGA infant became non-significant when GDM (yes/no) was further adjusted as a cofounding factor following the same covariates as above in the regression models ([[Supplemental Table](http://www.dovepress.com/get_supplementary_file.php?f=251846.docx)]{.ul}).

ROC Curve Analyses of Triglyceride-Associated Indicators of GDM Development and LGA Infant Delivery {#S0003-S2004}
---------------------------------------------------------------------------------------------------

The AUC values for detecting GDM and LGA infant by TG/HDL-c and TyG, as well as HOMA-IR, are shown in [Table 4](#T0004){ref-type="table"}. As for the detection of GDM, all three indices showed significant areas under the ROC curve (*P* \< 0.001 for all, [Table 4](#T0004){ref-type="table"} and [Figure 2](#F0002){ref-type="fig"}). Among of them, the AUC value and 95% CI for TyG was almost the same as that for HOMA-IR, but was slightly higher than that for TG/HDL-c. Further, the differences in AUC values among the three indices were also compared. According to the method described by DeLong,[@CIT0034] there were no significant differences among them (TG/HDL-c vs HOMA-IR, z = 1.878, *P* = 0.06; TyG vs HOMA-IR, z = 0.019, *P* = 0.985; TyG vs TG/HDL-c, z = 0.515, *P* = 0.607).Table 4Area Under Curve (AUC) and Corresponding 95% Confidence Interval (CI) of the Two Indices and HOMA-IR for Detecting GDM Development and LGA Infant DeliveryVariablesGestational Diabetes MellitusLarge for Gestational Age InfantSEAUC (95% CI)*P*SEAUC (95% CI)*P*HOMA-IR0.350.685 (0.614--0.756)\<0.0010.0470.603 (0.511--0.696)0.057TyG0.360.686 (0.615--0.756)\<0.0010.0470.643 (0.552--0.735)0.008TG/HDL-c0.350.664 (0.595--0.733)\<0.0010.0450.646 (0.559--0.734)0.007[^5] Figure 2Receiver operating characteristic (ROC) curves of triglyceride-associated indices and HOMA-IR used to predict GDM development.

The AUC of TG/HDL-c, TyG index and HOMA-IR to detect LGA infant delivery was 0.646 (95% CI, 0.559--0.734, *P*=0.007), 0.643 (95% CI, 0.552--0.735, *P*=0.008) and 0.603 (95% CI, 0.511--0.696, *P*=0.057), respectively ([Table 4](#T0004){ref-type="table"} and [Figure 3](#F0003){ref-type="fig"}). Likewise, differences in AUC values between the two triglyceride-associated indices were also compared. According to the above method, there were no significant differences among them (TyG vs TG/HDL-c, z = 0.0992, *P* = 0.921).Figure 3Receiver operating characteristic (ROC) curves of triglyceride-associated indices and HOMA-IR used to predict LGA infant delivery.

Discussion {#S0004}
==========

The present study showed that women who developed GDM had significantly increased TG/HDL-c ratios and TyG values in early pregnancy compared with controls; women with TG/HDL-c ratios or TyG values in the top tertile had a significantly higher risk of developing GDM and delivering LGA infants than did those with TG/HDL-c ratios or TyG values in the lowest tertile, suggesting that both TG/HDL-c and TyG at the time of the first trimester of pregnancy are independently and significantly associated with the later development of GDM and LGA infant delivery, which strengthens previous findings.[@CIT0028]--[@CIT0030] There were no statistical differences between TG/HDL-c and TyG in the ability of predicting the risk of GDM or LGA.

The overall incidence of GDM (18.8%) in this study was slightly higher than that reported in a recent meta-analysis where the average incidence of GDM was estimated to be 15%.[@CIT0002] Possible explanations might include: 1) more than 50% of pregnant women in the study population have less than 150 minutes of moderate exercise per week; 2) women with BMI ≥ 24.0 kg/m^2^ at the time of enrolment accounted for 30.1% (n=109) of the study population. These factors might be associated with the high incidence of GDM.

An elevated serum level of TGs is common in pregnant women, especially in GDM pregnancies, and this may be associated with insulin resistance, relative lack of insulin secretion and oxidative stress.[@CIT0029] Several studies have found that hypertriglyceridemia, even in early pregnancy,[@CIT0017] is associated with insulin resistance as well as GDM.[@CIT0018]--[@CIT0021] Enquobahrie et al found that each 20 mg/dl increase in TG concentration leads to a 10% rise in the risk of GDM. Also, they demonstrated that mothers with TG levels more than 137 mg/dl were 3.5 times more likely to develop GDM.[@CIT0035] Furthermore, it has been confirmed that the level of maternal TGs has an independent and strong association with birth weight, whether women have GDM or not.[@CIT0036]--[@CIT0039] There are some pathophysiological reasons for the increased risk of macrosomia in pregnant women with hypertriglyceridemia. Serum level of TGs is subject to significant changes in pregnancy trimesters. In the first trimester of pregnancy, insulin sensitivity and lipoprotein lipase activity increase. Conversely, the lipoprotein lipase activity decreases in the third trimester of pregnancy due to the increase in insulin resistance, a phenomenon which is more prominent in GDM.[@CIT0040] The derived fatty acids enter the umbilical cord blood, are stored in fetal adipose tissues, and result in increased fetal growth and adiposity.[@CIT0041] In addition, the serum concentration of HDL-c has been reported to be negatively associated with the risk for GDM and macrosomia and a moderate rise in concentration of HDL-c is a protective factor for both of them.[@CIT0042] Therefore, TG/HDL-c, an index combined of TG and HDL-c, has been demonstrated to be associated with both GDM and LGA infant delivery,[@CIT0029] as reported by Wang et al, the area under ROC curve of TG/HDL-c to detect GDM was 0.617 (95% CI, 0.548--0.686), and when the TG/HDL-c combined with HbA1c, the area under the combined ROC curve could be improved to 0.705 (95% CI, 0.637--0.772), suggesting that the sensitivity and specificity of TG/HDL-c in predicting GDM risk could be improved by the concurrent measurement of HbA1c in pregnant women. Although we were unable to perform the similar analyses due to the lack of data on HbA1c, our study also found the potential of TG/HDL-c for detecting the risk of GDM with an AUC of 0.664 (0.595--0.733), a result which is consistent with the previous one.[@CIT0029] Interestingly, Santos-Weis et al have suggested the logarithm of TG/HDL-c ratio in early pregnancy is a valuable index to identify pregnant women with low risk of GDM before 24 weeks of gestation.[@CIT0043]

In addition, fasting glucose level in early pregnancy is also an accurate indicator for the prediction of GDM.[@CIT0044] A recent study has confirmed that the risk of GDM can be predicted by the combination of maternal age, pre-pregnancy BMI, FPG and TG during 8--20 weeks of gestation with an AUC of 0.766 (95% CI 0.731--0.801).[@CIT0045] In our study, we did analyse an index combined TG and FPG--the TyG index, which has been reported to be closely associated with insulin resistance in general population,[@CIT0024]--[@CIT0026] as well as in pregnancies.[@CIT0028] Furthermore, a recent study has reported that the relative risk of GDM and LGA infants in women in the top levels (\> 66.6th percentile) of TyG index among the study population was 4.9-folds and 5.3-folds of its risk in women in the bottom levels.[@CIT0030] Likewise, we also found women in the highest tertile of TyG index had a significantly higher risk of developing GDM and delivering LGA infants than women in the lowest tertile in this study.

Since HOMA-IR is a recognized indicator of insulin resistance, the predictive ability of HOMA-IR to GDM was also analysed using ROC curve analysis with the purpose of comparing it with the two TG-associated indices. To be noted, the AUC value and 95% CI for TyG index to detect GDM was almost the same as HOMA-IR, which suggests TyG index is a good indicator of insulin resistance in early pregnancy.[@CIT0028]

Furthermore, we compared the ability of TG/HDL-c and TyG index to predict the risk of GDM and LGA infant delivery with the purpose of finding a better index to predict later pregnancy complications in early period of pregnancy. However, we found that there were no statistical differences among them in the ability of predicting the risk of GDM or LGA infant.

In addition to the above, it is important to note that the associations between the two TG-associated indices and the risk of LGA infant became non-significant when GDM status was further adjusted as a cofounding factor following other covariates ([[Supplemental Table](http://www.dovepress.com/get_supplementary_file.php?f=251846.docx)]{.ul}), which is inconsistent with a more recent study in which maternal lipids are significantly associated with newborn adiposity independent of GDM status.[@CIT0046] The potential explanation for this discrepancy may be due to the different points of time in the measurement of serum lipid profile (including TG, TC, HDL-c and LDL-c), whether there are other reasons remains to be further investigated.

Strengths and Limitations {#S0005}
=========================

The strengths of our study are the prospective design, as well as its careful recording of obstetric complications by researchers who were blind to the serum lipids of the participants. In consistence with previous studies,[@CIT0028]--[@CIT0030] this study confirmed the ability of TG/HDL-c and TyG index to predict the risk of later GDM and LGA infant delivery. As well, blood samples were collected at the first trimester of pregnancy, which may provide earlier data support and more time for intervention to prevent or reduce the occurrence of pregnancy complications. On the other side, our study has several limitations that should be noted. First, we did not collect adequate information regarding dietary factors which could act as potential confounders. Second, we did not consider other variables such as a previous history of LGA infant delivery.

Conclusions {#S0006}
===========

In conclusion, this preliminary cohort study determined that maternal first-trimester TG/HDL-c and TyG could be useful in predicting later development of GDM and LGA infant in Chinese pregnant women. Further, this study confirmed that there is no difference between the two indices in the prediction of GDM and LGA infant delivery. Therefore, they can be used as alternative indices in evaluation the risk of complications during pregnancy and perinatal period.
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[^1]: **Notes:** ^a^Represents weight gain from enrolment to the 75-g oral glucose tolerance test. ^b^Represents weight gain from enrolment to before childbirth.

[^2]: **Abbreviations:** TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment-insulin resistance; DM, diabetes mellitus; PCOS, polycystic ovary syndrome; LGA, large for gestational age.

[^3]: **Abbreviations:** TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; CRP, C-reactive protein; TyG, triglyceride glucose index; TC, total cholesterol.

[^4]: **Notes:** ^†^adjusted for age, education, physical activity, BMI (at enrolment), parity, family history of diabetes, history of PCOS, CRP and weight gain (from enrolment to the 75-g oral glucose tolerance test); ‡adjusted for age, education, physical activity, BMI (at enrolment), parity, family history of diabetes, history of PCOS, CRP, labor method, fetal sex, gestation age and weight gain (from enrolment to before childbirth); \**p*\<0.05, \*\**p*\<0.01.

    **Abbreviations:** TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; TC, total cholesterol.

[^5]: **Abbreviations:** SE, standard error; HOMA-IR, homeostasis model assessment-insulin resistance; TyG, triglyceride glucose index; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol.
